Reference : New appendix criteria open for a broader concept of chronic migraine.
Scientific journals : Article
Human health sciences : Neurology
Social & behavioral sciences, psychology : Neurosciences & behavior
New appendix criteria open for a broader concept of chronic migraine.
Olesen, J. [> > > >]
Bousser, M*-G [> > > >]
Diener, H*-C [> > > >]
Dodick, D. [> > > >]
First, M. [> > > >]
Goadsby, P. J. [> > > >]
Gobel, H. [> > > >]
Lainez, M. J. A. [> > > >]
Lance, J. W. [> > > >]
Lipton, R. B. [> > > >]
Nappi, G. [> > > >]
Sakai, F. [> > > >]
Schoenen, Jean mailto [Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Neuro-anatomie >]
Silberstein, S. D. [> > > >]
Steiner, T. J. [> > > >]
Blackwell Science
Yes (verified by ORBi)
Osney Mead Oxford
United Kingdom
[en] Chronic Disease ; Diagnosis, Differential ; Diagnosis-Related Groups/standards ; Humans ; Internationality ; Migraine Disorders/classification/diagnosis ; Pain Measurement/standards ; Practice Guidelines as Topic/standards ; Terminology as Topic
[en] After the introduction of chronic migraine and medication overuse headache as diagnostic entities in The International Classification of Headache Disorders, Second Edition, ICHD-2, it has been shown that very few patients fit into the diagnostic criteria for chronic migraine (CM). The system of being able to use CM and the medication overuse headache (MOH) diagnosis only after discontinuation of overuse has proven highly unpractical and new data have suggested a much more liberal use of these diagnoses. The International Headache Classification Committee has, therefore, worked out the more inclusive criteria for CM and MOH presented in this paper. These criteria are included in the appendix of ICHD-2 and are meant primarily for further scientific evaluation but may be used already now for inclusion into drug trials, etc. It is now recommended that the MOH diagnosis should no longer request improvement after discontinuation of medication overuse but should be given to patients if they have a primary headache plus ongoing medication overuse. The latter is defined as previously, i.e. 10 days or more of intake of triptans, ergot alkaloids mixed analgesics or opioids and 15 days or more of analgesics/NSAIDs or the combined use of more than one substance. If these new criteria for CM and MOH prove useful in future testing, the plan is to include them in a future revised version of ICHD-2.

File(s) associated to this reference

Fulltext file(s):

Restricted access
New appendix Olesen et al 2006.pdfPublisher postprint60.62 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.